These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
842 related articles for article (PubMed ID: 6294651)
21. Transient gene expression control: effects of transfected DNA stability and trans-activation by viral early proteins. Alwine JC Mol Cell Biol; 1985 May; 5(5):1034-42. PubMed ID: 2987671 [TBL] [Abstract][Full Text] [Related]
22. Mechanism of transfection of chicken embryo fibroblasts by Rous sarcoma virus DNA. Cooper GM; Okenquist S J Virol; 1978 Oct; 28(1):45-52. PubMed ID: 212612 [TBL] [Abstract][Full Text] [Related]
23. Herpes simplex virus type 1 alpha gene containing plasmids can inhibit expression regulated from an alpha promoter in CV-1 but not HeLa cells. Block T; Jordan R Virus Res; 1988 Nov; 11(4):269-79. PubMed ID: 2851895 [TBL] [Abstract][Full Text] [Related]
24. Tissue-specific activity of heterologous viral promoters in primary rat hepatocytes and Hep G2 cells. Fang XJ; Keating A; de Villiers J; Sherman M Hepatology; 1989 Nov; 10(5):781-7. PubMed ID: 2807156 [TBL] [Abstract][Full Text] [Related]
25. Proposed gag-encoded transcriptional activator is not necessary for Rous sarcoma virus replication or transformation. Carlberg K; Beemon K J Virol; 1988 Nov; 62(11):4003-8. PubMed ID: 2459410 [TBL] [Abstract][Full Text] [Related]
27. Introduction of UAG, UAA, and UGA nonsense mutations at a specific site in the Escherichia coli chloramphenicol acetyltransferase gene: use in measurement of amber, ochre, and opal suppression in mammalian cells. Capone JP; Sedivy JM; Sharp PA; RajBhandary UL Mol Cell Biol; 1986 Sep; 6(9):3059-67. PubMed ID: 3023959 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies. Mukhtar M; Duan L; Bagasra O; Pomerantz RJ Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098 [TBL] [Abstract][Full Text] [Related]
29. Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene. Staprans SI; Rabert DK; Spector DH J Virol; 1988 Sep; 62(9):3463-73. PubMed ID: 2841497 [TBL] [Abstract][Full Text] [Related]
30. Identification of a functional promoter in the long terminal repeat of Rous sarcoma virus. Yamamoto T; de Crombrugghe B; Pastan I Cell; 1980 Dec; 22(3):787-97. PubMed ID: 6257399 [TBL] [Abstract][Full Text] [Related]
31. Heterologous gene expression in avian cells: potential as a producer of recombinant proteins. Lee S; Kim SH; Kim VN; Hwang JH; Jin M; Lee J; Kim S J Biomed Sci; 1999 Jan; 6(1):8-17. PubMed ID: 9933737 [TBL] [Abstract][Full Text] [Related]
32. Identification of EFIV, a stable factor present in many avian cell types that transactivates sequences in the 5' portion of the Rous sarcoma virus long terminal repeat enhancer. Houtz EK; Conklin KF J Virol; 1996 Jan; 70(1):393-401. PubMed ID: 8523553 [TBL] [Abstract][Full Text] [Related]
33. Functional analysis of the long terminal repeats of intracisternal A-particle genes: sequences within the U3 region determine both the efficiency and direction of promoter activity. Christy RJ; Huang RC Mol Cell Biol; 1988 Mar; 8(3):1093-102. PubMed ID: 2452971 [TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli. Kashanchi F; Wood C Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2157-61. PubMed ID: 2648391 [TBL] [Abstract][Full Text] [Related]
35. Tissue-specific expression in transgenic mice of a fused gene containing RSV terminal sequences. Overbeek PA; Lai SP; Van Quill KR; Westphal H Science; 1986 Mar; 231(4745):1574-7. PubMed ID: 3006249 [TBL] [Abstract][Full Text] [Related]
36. In vitro transfection of fresh thymocytes and T cells shows subset-specific expression of viral promoters. Novak TJ; Yoshimura FK; Rothenberg EV Mol Cell Biol; 1992 Apr; 12(4):1515-27. PubMed ID: 1312665 [TBL] [Abstract][Full Text] [Related]
37. Integration of Rous sarcoma virus DNA into chicken embryo fibroblasts: no preferred proviral acceptor site in the DNA of clones of singly infected transformed chicken cells. Lerner TL; Skalka AM; Hanafusa H J Virol; 1981 Nov; 40(2):421-30. PubMed ID: 6275096 [TBL] [Abstract][Full Text] [Related]
38. The GT-rich sequence in the U5 region of Rous sarcoma virus long terminal repeat is required for transcription termination and 3' processing. Cleavinger PJ; Kandala JC; Guntaka RV Folia Biol (Praha); 1997; 43(4):153-60. PubMed ID: 9338122 [TBL] [Abstract][Full Text] [Related]
39. Mammalian expression constructs based on the Rous sarcoma virus LTR in high yield plasmids. Omar C; Kamlin F; Parry GC; Rahman K; Malcolm AD; Kamalati T; Buluwela L Biochem Soc Trans; 1991 Apr; 19(2):139S. PubMed ID: 1653721 [No Abstract] [Full Text] [Related]
40. Characterization of the promoter for the alpha 1 (IV) collagen gene. DNA sequences within the first intron enhance transcription. Killen PD; Burbelo PD; Martin GR; Yamada Y J Biol Chem; 1988 Sep; 263(25):12310-4. PubMed ID: 2842328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]